Statistics
Total Visits
| Views | |
|---|---|
| A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: A study of the EORTC early clinical studies group (ECSG) | 133 |
Total Visits Per Month
| February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | |
|---|---|---|---|---|---|---|---|
| A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: A study of the EORTC early clinical studies group (ECSG) | 1 | 1 | 1 | 2 | 6 | 2 | 7 |
Top country views
| Views | |
|---|---|
| United States | 60 |
| Poland | 52 |
| China | 4 |
| France | 3 |
| Ireland | 3 |
| Argentina | 2 |
| Australia | 1 |
| Belgium | 1 |
| Germany | 1 |
| EU | 1 |
Top cities views
| Views | |
|---|---|
| Warsaw | 52 |
| Louisville | 12 |
| Boardman | 10 |
| Des Moines | 9 |
| San Ramon | 8 |
| Ann Arbor | 6 |
| Beijing | 4 |
| Ashburn | 3 |
| Dublin | 3 |
| Fairfield | 2 |